| DMRA Market Cap History Table | ||||||||
Below is a table of the DMRA market cap history going back to 11/3/2025:
Also see: DMRA Shares Outstanding History and DMRA YTD Return |
DMRA Market Cap History — Damora Therapeutics Capitalization Over Time
As of 5/11/2026 Damora Therapeutics has a market cap of 1.50 billion. Investors often follow the DMRA market cap history to compare the size of the company over time.
This page shows DMRA market capitalization trends over time, with 3 market cap datapoints presented, dating back to 11/3/2025.
| DMRA Market Cap History Chart | |||||||||
DMRA Historical Market Cap: +32543.52% CAGR 
Mouse over chart for data details
| |||||||||
| DMRA Stock Price Chart |
| About Damora Therapeutics Inc |
| Galecto, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing novel treatments for cancer and liver diseases. Co.'s pipeline consists small molecule drug candidates that target cancer and fibrosis signaling pathways, including an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications; and a preclinical dual inhibitor of ENL-YEATS and FLT3 (BRM-1420) for multiple genetic subsets of acute myeloid leukemia (AML). We show 3 historical shares outstanding datapoints in our DMRA shares outstanding history coverage, used to compute DMRA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DMRA market cap history over the course of time is important for investors interested in comparing DMRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DMRA versus a peer is one thing; comparing DMRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DMRA can fluctuate over the course of history. With this page we aim to empower investors researching DMRA by allowing them to research the DMRA market cap history. |
| DMRA Current Stock Quote |
Quotes delayed 20 minutes  Free DMRA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| DMRA Share Performance |
| Market Cap Peers |
| Damora Therapeutics (DMRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DMTK Market Cap History DNAY Market Cap History DNLI Market Cap History DNTH Market Cap History DOMH Market Cap History DOVA Market Cap History DPLO Market Cap History DRAD Market Cap History DRIO Market Cap History DRMA Market Cap History More Healthcare companies » |
DMRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
